Member Info for mafioso

Low. To mid income countries

That is incorrect

GAD is equivalent to ODX in that they are set up to manufacture diagnostic kits for Mologic.

Big difference being they are set up as an independent non-profit company aimed to support production of these tests to low to mid incOme companies to make them affordable.

ODX is not part of this as it will cost them too much money to manufacture for no profit.

This thread is merely trying to stall the price to allow more top up.

All RNS coming out from this company will be carefully timed
TB is a seasoned stockbroker and BoD knows exactly what news to put out and when to get desired effect

You won’t get a better orchestrated news flow on AIM stock than this to flag momentum triggers

GAD is linked to Mologic and is independent and non profit making.

This tender is linked to the update Mologic gave on Dec 24 on their knew LFD test where they state

To guarantee access to the rapid test in low- and middle-income countries, the COVID-19 Rapid Antigen Test will be manufactured and made available by Global Access Diagnostics (GAD), at cost of production and distributed through commercialisation partners.

https://mologic.co.uk/mologic-receives-ce-mark-approval-for-professional-use-covid-19-rapid-antigen-test/

ODX has nothing to do with this tender

They are most likely bot trades done by trading algo

Zero - the main reason for rNS of truck leaving was to stop and reverse the recent negative RNS and negative sentiment on the sp and give the market more certainty and a virtual buy signal.

This then reversed the sp downturn and the sp has surged since to the point that today it rose by over 35% this morning which triggered the speeding ticket due to Nomad intervention which is typical of such big day rises when no RNS has been issued. It is standard practice in AIM to do this.

But the key thing to know that all along TB and BOD have been provided early flags notices of what their intention are with news flow. positives and negative. And this is an important factor in AIM as well as fundamentals

TB did exactly same play with BRH on 24 Dec. And then look at that what happened since then on that sp
TB and BoD knows exactly what they are doing to move the sp where they want it to go. Everyone knows what news is coming and is giving everyone still time to get on board at a reasonable sp

It’s like a train picking up investors at the last few stop before a non stop journey to destination riches.

This is not a recent article as it doesn’t even appear in latest news for Dec or Jam. This would have been pre vaccine news.

We just don’t know what the new protocol for testing now that vaccines are taking priority. We Just have to keep waiting on news from OdX and RTC

GM date likely to be next RNS

BRH up similar amount. They probably bought back in to RMS at placing

Paul Ryan still has a major interest albeit all in Share Options that are exercisable @1.4p. No info when these mature

See below Rns on 18 Nov

18 November 2020

Remote Monitored Systems plc ("RMS" or the "Company")

Director Dealing

The Company has been notified that Paul Ryan, Non-Executive Chairman of the Company, has sold 28,942,970 ordinary shares in the Company.



Following this transaction, Paul Ryan holds no shares in the Company. He continues to hold 38,801,756 share options at an exercise price of 1.4p per share.

He had sold all his shares by 18 Nov , so was no longer a major shareholders

Main reason sp being kept down is cos 400m new shares from Placing are being issued tomorrow am for trading

Sorry - try this link

https://www.ox.ac.uk/sites/files/oxford/media_wysiwyg/UK%20evaluation_PHE%20Porton%20Down%20%20University%20of%20Oxford_final.pdf

Try to keep feet on ground and stick to facts as much as you are to make rationale decisions

On bidstats, no mention of affirmer on either version tender

https://bidstats.uk/tenders/?q=Covid&ntype=tender&value=high#739639295-738656

So we are clinging onto hope

Also, found this report around LFDs being tested by Porton Down for PHE.

Started with 40 LFD brands, down to 6, and one in final stages of clinical trilas which is Innova.

So head is saying that Innova is only LFD in position to win tender, but my hope it could be multiple contracts Including Avacta including if roll-out is phased to give more time. It’s a punt for sure right now

https://www.ox.ac.uk/sites/files/oxford/media_wysiwyg/UK%20evaluation_PHE%20Porton%20Down%20%

My bad - It’s Astrazenica trialing yet another treatment which is not classed as a vaccine but not ready till spring apparently

Mention of Covid treatment in final phase in headline summary to treat those who who can’t take vaccine.

This could be SNG

Tyra - It’s simple. Press Coverage of Vaccines in past 2 weeks has gazzumped all other Covid plays. It’s been pushed to the max By the 3 major players taking it un turns to outdo each other with releases and updates on performance. Nothing else is getting enough airplay or column inches in the tabloids to notice. You only see them in investor magazines at best

Patience needed here and lots of it’s as vaccienis on hyper train I feel and is not close to reality of what practicalities are of rolling it this winter in this current wave 2 phase of pandemic.

Talk:of 1 million of administering vaccines per week in Q1 is pure hype imo

https://www.bmj.com/content/371/bmj.m4460

Check out this Artcile on Moonshoot. Look at bottom section of artiicle around size of tender orders of LFTs. Numbers are mind boggling if true. and then look at this link which is next to footnote of one of the tenders

https://bidstats.uk/tenders/2020/W46/738590726

Tender for £912m has just expired for LFT test for manufacture in Q1 for professional use

If Avacta has won this, it’s going to the moon!

Looks like a double bear trap. First @330 and now @280. Total write off for even trading . Bears in control